3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Carcinoma, Merkel Cell
1
Carcinoma, Basal Cell
1
Interventions
Specimen Handling
482
pembrolizumab
454
Magnetic Resonance Spectroscopy
419
Carboplatin
321
Cyclophosphamide
314
Biopsy
272
Cisplatin
264
Radiotherapy
241
Paclitaxel
226
Gemcitabine
224
Bevacizumab
212
Nivolumab
189
fludarabine
183
venetoclax
172
Drug Therapy
166
Dexamethasone
157
Blood Specimen Collection
156
Oxaliplatin
154
Injections
152
Capecitabine
152
Fluorouracil
144
Docetaxel
143
Standard of Care
136
Radiosurgery
136
Rituximab
125
Pemetrexed
115
durvalumab
113
atezolizumab
110
Leucovorin
110
Radiation
105
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Predictive Learning Models
×
1 year
×
Clear all
NCT06536257
2025-09-18
PIP-PREDICT
Melanoma Institute Australia
Recruiting
1,000 enrolled